Danielle Fishel shared her breast cancer diagnosis this week, revealing on Monday’s episode of her podcast, “Pod Meets World,” that she is being treated for ductal carcinoma in situ.

The prognosis for ductal carcinoma in situ is excellent. Regardless of what local treatment options patients may choose, their survival from this kind of breast cancer is in the range of about 99 ...

Ductal carcinoma in situ: Is it cancer?The argument rages on about whether ductal carcinoma in situ (referred to here as "breast cancer light") should be treated as breast cancer when, some ...

Ductal carcinoma in situ treatments evolve over 20 years, but cancer death rates vary little Date: October 9, 2015 Source: Duke Medicine Summary: Treatment patterns for ductal carcinoma in situ ...

Risk of progression differs in high risk and low risk cases when surgery is omitted Ductal carcinoma in situ (DCIS) is a non-obligate precursor lesion of invasive breast cancer. Since the ...

Overview:Ductal carcinoma in situ (DCIS) is a heterogeneous group of diseases that differ in biology and clinical behavior. Until 1980, DCIS represented less than 1% of all breast cancer cases. With ...

Ductal carcinoma in situ (DCIS), the most common non-invasive lesion of the breast, presents unique challenges for patients and providers largely because the natural course of the untreated ...

DUCTAL CARCINOMA in situ (DCIS) is noninvasive breast cancer that encompasses a wide spectrum of diseases ranging from low-grade lesions that are not life threatening to high-grade lesions that may ...

Overall, 3,651 women with non-screen-detected ductal carcinoma in situ developed invasive breast cancer by December 2018, which was more than four times higher than expected based on national ...

Ductal carcinoma in situ (DCIS) is considered the earliest form of breast cancer. We asked our experts at Huntsman Cancer Institute to give an overview of the disease, including symptoms and ...